Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Lymphoid 1Head & Neck 1Gynecologic 1Genitourinary 1Gastrointestinal 1Dermatologic 1Breast 1

Conditions

Lymphoma, T-Cell, Cutaneous 13Mycosis Fungoides 6Lymphoma, T-Cell, Peripheral 4Lymphoma, Primary Cutaneous Anaplastic Large Cell 4Hodgkin Disease 4Sezary Syndrome 3Lymphomatoid Papulosis 3Lymphoma, T-Cell 3Lymphoma, Non-Hodgkin 3Squamous Cell Carcinoma of Head and Neck 2Recurrence 2Melanoma 2Lymphoma, Large-Cell, Anaplastic 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma 2Immunoblastic Lymphadenopathy 2Hematologic Diseases 2Dendritic Cell Sarcoma, Interdigitating 2Carcinoma, Non-Small-Cell Lung 2Waldenstrom Macroglobulinemia 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Subcutaneous panniculitis-like T-cell lymphoma 1Stomach Neoplasms 1Sarcoma, Kaposi 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Ovarian Neoplasms 1Lymphoma, Mantle-Cell 1

Interventions

pembrolizumab 24Nivolumab 13atezolizumab 7Ipilimumab 6Cyclophosphamide 6fludarabine 5Specimen Handling 5Magnetic Resonance Spectroscopy 5aldesleukin 4Interleukin-2 4Biopsy 4durvalumab 3cemiplimab 3Docetaxel 3tislelizumab 2osimertinib 2fludarabine phosphate 2enzalutamide 2avelumab 2X-Rays 2Ritonavir 2Radiotherapy 2Observation 2Methods 2Immunoglobulin G 2IFL protocol 2Drug Therapy 2zimberelimab 1utomilumab 1ulixertinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Uterine Cervical Neoplasms × Brentuximab Vedotin × Dermatologic × Clear all
NCT04254107 2025-02-10

A Safety Study of SEA-TGT (SGN-TGT) in Advanced Cancer

Seagen Inc.

Phase 1 Terminated
133 enrolled
BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckLymphoidThoracic

Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Melanoma, Ovarian Neoplasms, Stomach Neoplasms, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Peripheral, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡